Stockreport

Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights [Yahoo! Finance]

Clene Inc.  (CLNN) 
PDF The FDA advised Clene to request a Type C meeting to review these further ALS biomarker data analyses The Company plans to submit a New Drug Application (NDA) in the [Read more]